아시아첨가제

비상장계속사업자

Asia Stabilizers Co., Ltd

김형웅외1인

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

아시아첨가제

Business Reg. No. 1258118604 · CEO 김형웅외1인

I.Investment Overview

Target아시아첨가제 (1258118604)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명아시아첨가제
영문명Asia Stabilizers Co., Ltd
대표자김형웅외1인
사업자등록번호1258118604
법인등록번호1347110016596
설립일1996.04.24
종업원수87명

V.Workforce

87

Current headcount · 2026.07 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW663.72021824.1202261320235412024583.62025
영업이익100M KRW70.62021147.5202242.4202333202488.92025
순이익100M KRW58.62021114.4202235.2202332.8202469.52025
Item20252024202320222021
자산총계406.1억원364.7억원389억원447.3억원440.7억원
부채총계203억원199억원221.2억원200.6억원250.5억원
자본총계203.1억원165.6억원167.8억원246.6억원190.2억원
매출액583.6억원541억원613억원824.1억원663.7억원
영업이익88.9억원33억원42.4억원147.5억원70.6억원
순이익69.5억원32.8억원35.2억원114.4억원58.6억원

VII.Financial Ratios

FY2025 basis

15.24%

영업이익률

11.9%

순이익률

17.1%

ROA

34.2%

ROE

99.97%

부채비율

50.01%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

아시아첨가제 투심보고서 | Alpha Lenz